Standardizing scavenger receptor nomenclature

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 1997-2006

  PrabhuDas, Mercy ^a   Bowdish, Dawn ^b   Drickamer, Kurt ^c   Febbraio, Maria ^d   Herz, Joachim ^e   Kobzik, Lester ^f   Krieger, Monty ^g   Loike, John ^h   Means, Terry K ⁱ   Moestrup, Soren K ^j   Post, Steven ^k   Sawamura, Tatsuya ^l   Silverstein, Samuel ^h   Wang, Xiang Yang ^m   Khoury, Joseph El ⁱ  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j AARHUS UNIVERSITY   (Denmark)

^k UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^l NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^m VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR A1; SCAVENGER RECEPTOR A3; SCAVENGER RECEPTOR A5; SCAVENGER RECEPTOR A6; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR B2; SCAVENGER RECEPTOR B3; SCAVENGER RECEPTOR BI; SCAVENGER RECEPTOR D; SCAVENGER RECEPTOR E1; SCAVENGER RECEPTOR F; SCAVENGER RECEPTOR F1; SCAVENGER RECEPTOR F2; SCAVENGER RECEPTOR F3; SCAVENGER RECEPTOR G; SCAVENGER RECEPTOR G1; SCAVENGER RECEPTOR H; SCAVENGER RECEPTOR H1; SCAVENGER RECEPTOR H2; SCAVENGER RECEPTOR I; SCAVENGER RECEPTOR I1; SCAVENGER RECEPTOR I2; SCAVENGER RECEPTOR J; SCAVENGER RECEPTOR J1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL SURFACE; ENDOCYTOSIS; HUMAN; LIGAND BINDING; MOLECULAR RECOGNITION; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR BINDING; STANDARDIZATION;

ANIMALS; HUMANS; RECEPTORS, SCAVENGER; TERMINOLOGY AS TOPIC;

EID: 84896508586     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1490003     Document Type: Article

References (77)

1. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76: 333-337.
2. Brown, M. S., and J. L. Goldstein. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 223-261.
3. Russell, D. W., T. Yamamoto, W. J. Schneider, C. J. Slaughter, M. S. Brown, and J. L. Goldstein. 1983. cDNA cloning of the bovine low density lipoprotein receptor: feedback regulation of a receptor mRNA. Proc. Natl. Acad. Sci. USA 80: 7501-7505.
4. Sege, R. D., K. Kozarsky, D. L. Nelson, and M. Krieger. 1984. Expression and regulation of human low-density lipoprotein receptors in Chinese hamster ovary cells. Nature 307: 742-745.
5. Krieger, M. 1997. The other side of scavenger receptors: pattern recognition for host defense. Curr. Opin. Lipidol. 8: 275-280.
6. Gu, B. J., B. M. Saunders, S. Petrou, and J. S. Wiley. 2011. P2X7 is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP. J. Immunol. 187: 2365-2375.
7. Shibata, M., J. Ishii, H. Koizumi, N. Shibata, N. Dohmae, K. Takio, H. Adachi, M. Tsujimoto, and H. Arai. 2004. Type F scavenger receptor SREC-I interacts with advillin, a member of the gelsolin/villin family, and induces neurite-like outgrowth. J. Biol. Chem. 279: 40084-40090.
8. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hébert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176.
9. Riggs, B. L., R. Baron, W. J. Boyle, M. Drexner, S. Manolagas, T. J. Martin, A. F. Stewart, T. Suda, H. Yasuda, J. Aubin, and D. Goltzman; The American Society for Bone and Mineral Research President's Committee on Nomenclature. 2000. Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. Bone 27: 761-764.
10. Klos, A., E. Wende, K. J. Wareham, and P. N. Monk. 2013. International Union of Pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol. Rev. 65: 500-543.
11. Lodge, D. 2009. The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology 56: 6-21.
12. Brown, M. S., S. K. Basu, J. R. Falck, Y. K. Ho, and J. L. Goldstein. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J. Supramol. Struct. 13: 67-81.
13. Fogelman, A. M., M. E. Haberland, J. Seager, M. Hokom, and P. A. Edwards. 1981. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J. Lipid Res. 22: 1131-1141.
14. Kodama, T., P. Reddy, C. Kishimoto, and M. Krieger. 1988. Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 85: 9238-9242.
15. Kodama, T., M. Freeman, L. Rohrer, J. Zabrecky, P. Matsudaira, and M. Krieger. 1990. Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coils. Nature 343: 531-535.
16. Rohrer, L., M. Freeman, T. Kodama, M. Penman, and M. Krieger. 1990. Coiledcoil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 343: 570-572.
17. Dunne, D. W., D. Resnick, J. Greenberg, M. Krieger, and K. A. Joiner. 1994. The type I macrophage scavenger receptor binds to Gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA 91: 1863-1867.
18. Krieger, M., S. Acton, J. Ashkenas, A. Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268: 4569-4572.
19. El Khoury, J., S. E. Hickman, C. A. Thomas, L. Cao, S. C. Silverstein, and J. D. Loike. 1996. Scavenger receptor-mediated adhesion of microglia to b-Amyloid fibrils. Nature 382: 716-719.
20. Means, T. K., E. Mylonakis, E. Tampakakis, R. A. Colvin, E. Seung, L. Puckett, M. F. Tai, C. R. Stewart, R. Pukkila-Worley, S. E. Hickman, et al. 2009. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206: 637-653.
21. Canton, J., D. Neculai, and S. Grinstein. 2013. Scavenger receptors in homeostasis and immunity. Nat. Rev. Immunol. 13: 621-634.
22. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111: 927-930.
23. Wilkinson, K., and J. El Khoury. 2012. Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease. Int. J. Alzheimers Dis. 2012: 489456.
24. Suzuki, H., Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O. Ueda, H. Sakaguchi, T. Higashi, T. Suzuki, et al. 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296.
25. Fraser, I., D. Hughes, and S. Gordon. 1993. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 364: 343-346.
26. Elomaa, O., M. Kangas, C. Sahlberg, J. Tuukkanen, R. Sormunen, A. Liakka, I. Thesleff, G. Kraal, and K. Tryggvason. 1995. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 80: 603-609.
27. Jiang, Y., P. Oliver, K. E. Davies, and N. Platt. 2006. Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells. J. Biol. Chem. 281: 11834-11845.
28. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1: 509-516.
29. Stahl, P. D., and R. A. Ezekowitz. 1998. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10: 50-55.
30. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Bryant, R. T. White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
31. Hughes, D. A., I. P. Fraser, and S. Gordon. 1995. Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur. J. Immunol. 25: 466-473.
32. Becker, M., A. Cotena, S. Gordon, and N. Platt. 2006. Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response. Eur. J. Immunol. 36: 950-960.
33. Gough, P. J., D. R. Greaves, H. Suzuki, T. Hakkinen, M. O. Hiltunen, M. Turunen, S. Y. Herttuala, T. Kodama, and S. Gordon. 1999. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 19: 461-471.
34. Plüddemann, A., C. Neyen, and S. Gordon. 2007. Macrophage scavenger receptors and host-derived ligands. Methods 43: 207-217.
35. Ohtani, K., Y. Suzuki, S. Eda, T. Kawai, T. Kase, H. Keshi, Y. Sakai, A. Fukuoh, T. Sakamoto, H. Itabe, et al. 2001. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J. Biol. Chem. 276: 44222-44228.
36. Ingersoll, M. A., R. Spanbroek, C. Lottaz, E. L. Gautier, M. Frankenberger, R. Hoffmann, R. Lang, M. Haniffa, M. Collin, F. Tacke, et al. 2010. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115: e10-e19.
37. Acton, S., D. Resnick, M. Freeman, Y. Ekkel, J. Ashkenas, and M. Krieger. 1993. The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J. Biol. Chem. 268: 3530-3537.
38. Whelan, F. J., C. J. Meehan, G. B. Golding, B. J. McConkey, and D. M. Bowdish. 2012. The evolution of the class A scavenger receptors. BMC Evol. Biol. 12: 227.
39. Selman, L., K. Skjodt, O. Nielsen, C. Floridon, U. Holmskov, and S. Hansen. 2008. Expression and tissue localization of collectin placenta 1 (CL-P1, SRCL) in human tissues. Mol. Immunol. 45: 3278-3288.
40. Arredouani, M., Z. Yang, Y. Y. Ning, G. Qin, R. Soininen, K. Tryggvason, and L. Kobzik. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J. Exp. Med. 200: 267-272.
41. van der Laan, L. J. W., E. A. Döpp, R. Haworth, T. Pikkarainen, M. Kangas, O. Elomaa, C. D. Dijkstra, S. Gordon, K. Tryggvason, and G. Kraal. 1999. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J. Immunol. 162: 939-947.
42. Asch, A. S., J. Barnwell, R. L. Silverstein, and R. L. Nachman. 1987. Isolation of the thrombospondin membrane receptor. J. Clin. Invest. 79: 1054-1061.
43. Ockenhouse, C. F., and J. D. Chulay. 1988. Plasmodium falciparum sequestration: OKM5 antigen (CD36) mediates cytoadherence of parasitized erythrocytes to a myelomonocytic cell line. J. Infect. Dis. 157: 584-588.
44. Coburn, C. T., F. F. Knapp, Jr., M. Febbraio, A. L. Beets, R. L. Silverstein, and N. A. Abumrad. 2000. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275: 32523-32529.
45. Gu, X., B. Trigatti, S. Xu, S. Acton, J. Babitt, and M. Krieger. 1998. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem. 273: 26338-26348.
46. Stuart, L. M., J. Deng, J. M. Silver, K. Takahashi, A. A. Tseng, E. J. Hennessy, R. A. B. Ezekowitz, and K. J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170: 477-485.
47. Stewart, C. R., L. M. Stuart, K. Wilkinson, J. M. Van Gils, J. Deng, A. Halle, K. J. Rayner, L. Boyer, R. Zhong, W. A. Frazier, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11: 155-161.
48. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520.
49. Krieger, M. 1999. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu. Rev. Biochem. 68: 523-558.
50. Ashraf, M. Z., and N. Gupta. 2011. Scavenger receptors: implications in atherothrombotic disorders. Int. J. Biochem. Cell Biol. 43: 697-700.
51. Braun, A., B. L. Trigatti, M. J. Post, K. Sato, M. Simons, J. M. Edelberg, R. D. Rosenberg, M. Schrenzel, and M. Krieger. 2002. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ. Res. 90: 270-276.
52. Covey, S. D., M. Krieger, W. Wang, M. Penman, and B. L. Trigatti. 2003. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler. Thromb. Vasc. Biol. 23: 1589-1594.
53. Webb, N. R., P. M. Connell, G. A. Graf, E. J. Smart, W. J. S. De Villiers, F. C. De Beer, and D. R. Van der Westhuyzen. 1998. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273: 15241-15248.
54. Song, L., C. Lee, and C. Schindler. 2011. Deletion of the murine scavenger receptor CD68. J. Lipid Res. 52: 1542-1550.
55. Hao, L., J. Klein, and M. Nei. 2006. Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals. Proc. Natl. Acad. Sci. USA 103: 3192-3197.
56. Yoshimoto, R., Y. Fujita, A. Kakino, S. Iwamoto, T. Takaya, and T. Sawamura. 2011. The discovery of LOX-1, its ligands and clinical significance. Cardivasc. Drugs Ther. 25: 379-391.
57. Sawamura, T., N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, and T. Masaki. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77.
58. Biocca, S., I. Filesi, R. Mango, L. Maggiore, F. Baldini, L. Vecchione, A. Viola, G. Citro, G. Federici, F. Romeo, and G. Novelli. 2008. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. J. Mol. Cell. Cardiol. 44: 561-570.
59. Herre, J., J. A. Willment, S. Gordon, and G. D. Brown. 2004. The role of Dectin-1 in antifungal immunity. Crit. Rev. Immunol. 24: 193-203.
60. Reid, D. M., M. Montoya, P. R. Taylor, P. Borrow, S. Gordon, G. D. Brown, and S. Y. Wong. 2004. Expression of the b-glucan receptor, Dectin-1, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions. J. Leukoc. Biol. 76: 86-94.
61. Adachi, H., M. Tsujimoto, H. Arai, and K. Inoue. 1997. Expression cloning of a novel scavenger receptor from human endothelial cells. J. Biol. Chem. 272: 31217-31220.
62. Ramirez-Ortiz, Z. G., W. F. Pendergraft, III, A. Prasad, M. H. Byrne, T. Iram, C. J. Blanchette, A. D. Luster, N. Hacohen, J. El Khoury, and T. K. Means. 2013. The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat. Immunol. 14: 917-926.
63. Ishii, J., H. Adachi, J. Aoki, H. Koizumi, S. Tomita, T. Suzuki, M. Tsujimoto, K. Inoue, and H. Arai. 2002. SREC-II, a new member of the scavenger receptor type F family, trans-interacts with SREC-I through its extracellular domain. J. Biol. Chem. 277: 39696-39702.
64. Shimaoka, T., N. Kume, M. Minami, K. Hayashida, H. Kataoka, T. Kita, and S. Yonehara. 2000. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J. Biol. Chem. 275: 40663-40666.
65. Matloubian, M., A. David, S. Engel, J. E. Ryan, and J. G. Cyster. 2000. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1: 298-304.
66. Sheikine, Y., and A. Sirsjö . 2008. CXCL16/SR-PSOX: a friend or a foe in atherosclerosis? Atherosclerosis 197: 487-495.
67. Wilbanks, A., S. C. Zondlo, K. Murphy, S. Mak, D. Soler, P. Langdon, D. P. Andrew, L. Wu, and M. Briskin. 2001. Expression cloning of the STRL33/ BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 166: 5145-5154.
68. Fukumoto, N., T. Shimaoka, H. Fujimura, S. Sakoda, M. Tanaka, T. Kita, and S. Yonehara. 2004. Critical roles of CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis. J. Immunol. 173: 1620-1627.
69. Shimaoka, T., T. Nakayama, K. Hieshima, N. Kume, N. Fukumoto, M. Minami, K. Hayashida, T. Kita, O. Yoshie, and S. Yonehara. 2004. Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain. J. Biol. Chem. 279: 26807-26810.
70. Park, S. Y., M. Y. Jung, S. J. Lee, K. B. Kang, A. Gratchev, V. Riabov, J. Kzhyshkowska, and I. S. Kim. 2009. Stabilin-1 mediates phosphatidylserine- dependent clearance of cell corpses in alternatively activated macrophages. J. Cell Sci. 122: 3365-3373.
71. Park, S. Y., M. Y. Jung, H. J. Kim, S. J. Lee, S. Y. Kim, B. H. Lee, T. H. Kwon, R. W. Park, and I. S. Kim. 2008. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 15: 192-201.
72. Schledzewski, K., C. Géraud, B. Arnold, S.Wang, H. J. Gröne, T.Kempf, K. C.Wollert, B. K. Straub, P. Schirmacher, A. Demory, et al. 2011. Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J. Clin. Invest. 121: 703-714.
73. Kristiansen, M., J. H. Graversen, C. Jacobsen, O. Sonne, H. J. Hoffman, S. K. Law, and S. K. Moestrup. 2001. Identification of the haemoglobin scavenger receptor. Nature 409: 198-201.
74. Thomsen, J. H., A. Etzerodt, P. Svendsen, and S. K. Moestrup. 2013. The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging. Oxid. Med. Cell. Longev. 2013: 523652.
75. Nielsen, M. J., M. Madsen, H. J. Moller, and S. K. Moestrup. 2006. The macrophage scavenger receptor CD163: endocytic properties of cytoplasmic tail variants. J. Leukoc. Biol. 79: 837-845.
76. Moeller, J. B., M. J. Nielsen, M. P. Reichhardt, A. Schlosser, G. L. Sorensen, O. Nielsen, I. Tornoe, J. Gronlund, M. E. Nielsen, J. S. Jorgensen, et al. 2012. CD163-L1 is an endocytic macrophage protein strongly regulated by mediators in the inflammatory response. J. Immunol. 188: 2399-2409.
77. Ibrahim, Z. A., C. L. Armour, S. Phipps, and M. B. Sukkar. 2013. RAGE and TLRs: relatives, friends or neighbours? Mol. Immunol. 56: 739-744.